O uso contínuo da terlipressina após a ligadura endoscópica em hemorragia varicosa aguda necessita de mais evidências: um estudo piloto / Rational for continuing terlipressin after endoscopic variceal ligation in acute variceal haemorrhage needs further evidence: a pilot study

ABSTRACT Background Variceal hemorrhage (VH) is a medical emergency. Prompt endoscopic variceal ligation (EVL) is therapeutic. Terlipressin is used in VH and continued for 2—5 days even after EVL. As hemostasis is primarily achieved by EVL, the benefit of continuing trelipressin after EVL is unknown. Objective To evaluate the efficacy of continuing terlipressin after EVL to prevent re-bleed and mortality. Methods In this pilot study, after EVL 74 patients of VH were randomized into two treatment groups TG2 & TG5, received terlipressin (1 mg IV bolus q 4 hourly) for 2 days and 5 days respectively and one control group (TG0), received 0.9% normal saline (10 mL IV bolus q 4 hourly) and followed up for 8 weeks. Results A total of 9 (12.6%) patients had re-bleed with maximum 4 (5.6%) patients in TG5 group followed by 3 (4.2%) in TG2 and 2 (2.8%) in TG0 groups (P=0.670). The overall mortality was 15 (21.1%) patients, 6 (8.5%) patients in TG0 group, followed by 5 (7.0%) in TG5 and 4 (5.6%) in TG2 group (P=0.691). Adverse drug reactions were significantly higher in treatment groups with maximum 18 (24.32%) patients in TG5, followed by 8 (10.8%) in TG2 and 2 (2.7%) in TG0 groups (P=0.00). Duration of hospital stay was also significantly higher in treatment group, 6.63 (±0.65) days in TG5 followed by 3.64 (±0.57) in TG2 and 2.40 (±0.50) days in TG0 groups (P=0.00). Conclusion The rational for continuing terlipressin after EVL is doubtful as it didn't have any benefit for the prevention of re-bleed or mortality; rather it increased the risk of adverse drug reactions and duration of hospital stay. Further randomized clinical trials are encouraged to generate more evidence in support or against continuing terlipressin after EVL.

RESUMO Contexto A hemorragia varicosa (HV) é emergência médica. A ligadura endoscópica imediata das varizes (LEV) é terapêutica. A terlipressina é usada em HV e contínua por 2—5 dias mesmo após a LEV. Como a hemostasia é alcançada principalmente pela LEV, o benefício do uso contínuo da terlipressina após o evento é desconhecido. Objetivo Avaliar a eficácia da terlipressina contínua após a LEV para evitar o ressangramento e a mortalidade. Métodos Neste estudo piloto, após a LEV, 74 pacientes com HV foram randomizados em dois grupos de tratamento TG2 & TG5, que receberam terlipressina (1 mg EV em bolus a cada 4 horas) durante 2—5 dias, respectivamente, e um grupo controle (TG0), que receberam soro fisiológico normal de 0,9% (10 mL EV em bolus a cada 4 horas) e foram seguidos por 8 semanas. Resultados Um total de 9 (12,6%) pacientes tiveram ressangramento, 4 (5,6%) no grupo TG5, seguidos por 3 (4,2%) no TG2 e 2 (2,8%) no grupo TG0 (P=0,670). A mortalidade geral de pacientes foi de 15 (21,1%), 6 (8,5%) no grupo TG0, seguidos por 5 (7,0%) no TG5 e 4 (5,6%) no TG2 (P=0,691). As reações adversas de medicamentos foram significativamente maiores em grupos de tratamento em 18 (24,32%) pacientes no TG5, seguidos por 8 (10,8%) no TG2 e 2 (2,7%) em grupo TG0 (P=0,00). A duração da internação hospitalar também foi significativamente maior no grupo de tratamento, 6,63 (±0,65) dias no TG5, seguido por 3,64 (±0,57) em TG2 e 2,40 (±0,50) dias em grupos TG0 (P=0,00). Conclusão O uso racional para a continuação da terlipressina após a LEV é duvidoso, pois não teve qualquer benefício para a prevenção de ressangramento ou mortalidade; pelo contrário, aumentou o risco de efeitos adversos e duração da internação hospitalar. Outros ensaios clínicos randomizados são necessários para gerar mais evidências em apoio ou contra a terlipressina contínua após a LEV.

Hemorragia Digestiva Alta por Dieulafoy intradiverticular: Tratamiento Endoscópico / Digestive Bleeding by Dieulafoy in Duodenal Diverticulum: Endoscopic Treatment

La Lesión de Dieulafoy es una malformación vascular caracterizada por la presencia de un vaso arterial de gran calibre en la submucosa, ocasionalmente en la mucosa que puede erosionarse, provocar una hemorragia grave, recurrente y, en ocasiones mortal. Es una causa rara de hemorragia gastrointestinal y corresponde a menos del 2% de los episodios de sangrado digestivo agudo. La Lesión de Dieulafoy duodenal ha sido comunicada en un número reducido de casos y, la intradiverticular es excepcional. La endoscopía constituye el método diagnóstico de elección y, en las últimas décadas la terapéutica endoscópica es la técnica preferida por su elevada efectividad y escasa incidencia de complicaciones. Presentamos el caso de un paciente de 82 años con hemorragia digestiva alta grave por lesión de Dieulafoy duodenal intradiverticular diagnosticado en la endoscopía de urgencia y, tratado eficazmente mediante ligadura con banda elástica.

The lesion of Dieulafoy is a vascular malformation characterized by the presence of a large arterial vessel in the submucosa and occasionally in the mucosa, which can erode and cause severe, recurrent and sometimes fatal hemorrhage. It is a rare cause of gastrointestinal bleeding and responds to less than 2% of episodes of acute gastrointestinal bleeding. The duodenal Dieulafoy lesion has been reported in a small number of cases and the intradiverticular is exceptional. Endoscopy is the diagnostic method of choice and in the last decade endoscopic therapy is the preferred technique due to its high effectiveness and low incidence of complications. We present the case of an 82-year-old patient with severe upper gastrointestinal bleeding due to an intradiverticular duodenal injury diagnosed in emergency endoscopy and treated effectively by rubber band ligation.

Manejo de epistaxis posterior en el Hospital Clínico de la Universidad de Chile entre los años 2013 y 2016 / Treatment of posterior epistaxis in the Clinical Hospital of the University of Chile between the years 2013 and 2016

Introducción: La epistaxis corresponde a una de las causas más frecuentes de consulta otorrinolaringológica en los servicios de urgencia. La epistaxis posterior es menos frecuente pero su presentación más severa. Existen varias alternativas terapéuticas, en las últimas décadas el manejo quirúrgico endoscópico de la arteria esfenopalatina (AEP) ha ido en aumento dado las ventajas en comodidad para el paciente y reducción de costos asociados. Objetivo: Revisar el manejo realizado en los cuadros de epistaxis posterior en el Hospital Clínico de la Universidad de Chile (HCUCh). Material y método: Estudio descriptivo en el Servicio de Otorrinolaringología del HCUCh de pacientes que presentaron epistaxis posterior entre el año 2013 y 2016. Resultados: Se revisó un total de 33 casos. La edad promedio de los pacientes fue 61,6 años siendo las comorbilidades más frecuentes la hipertensión arterial (36,3%) y fibrilación auricular (18,1%). Se realizó tratamiento quirúrgico en 57,6% de los pacientes siendo el clipaje de AEP la intervención quirúrgica más frecuente. Discusión y conclusiones: Tanto el manejo tradicional como las técnicas quirúrgicas presentaron eficacia similar en la serie revisada.

Introduction: Epistaxis corresponds to one of the most frequent causes of otorhinolaryngological consultation in the emergency services. Posterior epistaxis is less frequent but more severe. There are several therapeutic alternatives, in recent decades the surgical endoscopic management of the sphenopalatine artery (AEP) has been increasing given the advantages in comfort for the patient and reduction of associated costs. Aim: To review the management of posterior epistaxis in the Clinical Hospital of the University of Chile (HCUCh). Material and method: Descriptive study in the Otorhinolaryngology Service of the HCUCh of patients who presented posterior epistaxis between the years 2013 and 2016. Results: A total of 33 cases were reviewed. The mean age of the patients was 61.6 years, with the most frequent comorbidities being hypertension (36.3%) and atrial fibrillation (18.1%). Surgical treatment was performed in 57.6% of the patients, with AEP clipping being the most frequent surgical intervention. Conclusion: Both traditional management and surgical techniques presented similar efficacy in the revised series.

Tratamiento endoscópico de las epistaxis posteriores: Experiencia del Hospital Clínico de la Universidad de Chile entre los años 2007 y 2011 / Endoscopic treatment of posterior epistaxis: Experience at the Hospital Clínico de la Universidad de Chile between the years 2007 and 2011

Introducción: La epistaxis corresponde al motivo de consulta de urgencia más frecuente en otorrinolaringología. Su etiología es multifactorial, predominantemente de causa traumática. Una alternativa de manejo quirúrgico en los casos de epistaxis significativa es la cauterización o ligadura endoscópica de la arteria esfenopalatina (AEP). Objetivos: Este estudio pretende revisar la experiencia del Hospital Clínico de la Universidad de Chile en el manejo endoscópico de pacientes con epistaxis posterior. Material y método: Se revisaron los registros quirúrgicos del servicio entre los años 2007y 2011 considerando todos los pacientes que fueron tratados por epistaxis posterior mediante cirugía endoscópica nasal. Resultados: Se revisó un total de 23 casos. La edad promedio de los pacientes fue 52±18 años. Sesenta por ciento presentaba el antecedente de hipertensión arterial en tratamiento. Se realizó ligadura con clips más electrocauterización de AEP en 52,1% de los casos, ligadura con clips de AEP en 26,2%%, y electrocauterización de AEP en 21,7%% de los casos. Discusión y conclusiones: El manejo endoscópico de las epistaxis posteriores es una técnica sencilla y reproducible, constituyendo una herramienta terapéutica segura y eficaz para estos pacientes.

Introduction: Epistaxis is by far the most common emergency complaint in otolaryngology. Its etiology is multifactorial, predominantly by traumatic causes. An alternative in surgical management of significant epistaxis cases, is the endoscopic cauterization or ligature of the sphenopalatine artery (SPA). Aim: This study aims to review the experience of the Hospital Clínico de la Universidad de Chile in the endoscopic management of patients with posterior epistaxis. Material and methods: The surgical records have been reviewed between the years 2007and 2011, considering all patients who were treated for posterior epistaxis, by endoscopic nasal surgery. Results: A total of 23 cases were reviewed. The average age of patients was 52 ± 18 years. 60% of patients had a history of hypertension in treatment. Clip ligature with electrocauterization of the SPA was performed in 52.1% of cases, clip ligature of the SPA in 26.2%%, and isolated electrocauterization of the SPA in 21.7%% of cases. Discussion and conclusions: Endoscopic treatment of posterior epistaxis is a simple and reproducible technique, being a safe and effective therapeutic tool for these patients.

Respuesta a la terapia combinada vs monoterapia con betabloqueantes en profilaxis primaria de sangrado variceal en pacientes con cirrosis hepática / Response to combined therapy vs beta blockers monotherapy in the primary prophylaxis of bleeding esophageal varices in cirrhotics

Esta investigación tuvo como objetivo comparar los resultados del propanolol combinado o no con ligadura endoscópica (LE) en la profilaxis primaria del sangrado variceal en pacientes que acudieron al Servicio de Gastroenterología del Hospital Universitario de Maracaibo, durante los meses de Enero a Octubre 2009. La investigación fue de tipo correlacional, prospectiva, longitudinal. La población estuvo conformada por 40 pacientes entre 18 y 75 años de edad con Cirrosis Hepática y varices esofágicas de tamaño mediano-grande con o sin signos rojos, sin antecedentes de hemorragia digestiva superior. Se seleccionaron al azar 2 grupos, el primero estuvo representado por 20 pacientes, quienes fueron sometidos a LE combinado con Propanolol y el segundo por 20 pacientes tratados sólo con Propanolol. Para la recolección de datos se diseñó un cuestionario basado en las variables, dimensiones e indicadores propuestos en la investigación. Se demostró que el propanolol como monoterapia es tan efectivo como combinado con LE en la profilaxis primaria del sangrado variceal.

This research was aim to relate the results propranolol combined or not with endoscopic ligation (LE) in the primary prophylaxis of variceal bleeding in the Gastroenterology Service, Hospital Universitario de Maracaibo, during the months of January to October 2009. A correlational, prospective, longitudinal type study. The population was 40 patients between 18 and 75 years old with liver cirrhosis and esophageal varices of large-medium size, with no history of upper gastrointestinal bleeding. They were two randomly selected samples, the first is represented by 20 patients who underwent LE combined with propranolol and the second 20 patients treated with propranolol alone. For data collection a questionnaire was designed based on the variables, dimensions and indicators proposed in the research. We demonstrated that monotherapy with propranolol is as effective as combined with LE in the primary prophylaxis of variceal bleeding.

Ligadura endoscópica de várices de esófago / Endoscopic ligation of oesophageal varices

La ligadura endoscópica de várices de esófago es una técnica desarrollada por Stiegmann y colaboradores para el tratamiento de las várices sangrantes de esófago, que ha demostrado ser tan efectiva como la esclerosis endoscópica, con menor incidencia de complicaciones. Diversos estudios han mostrado que la ligadura endoscópica de várices es una alternativa promisoria a la escleroterapía.

Endoscopic rubber band liglation of esophageal varices is a technique developed by Stiegmann and co-workers in an attempt to provide an endoscopic treatment for bleeding esophageal varices that isat least as effective as endoscopic sclero therapy, but has a lower incidence of complications. Several studies have shown that endoscopic rubber band ligation of esophageal varices is a promising alternative to scierotherapy.